Heineman, Thomas

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 976% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Heineman, Thomas's trades of Oncolytics Biotech Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
191.66
Quantity 82,590 -15.8%
Value US$1,470,206
Transaction date
Purchase
Price
270.85
Quantity 40,442 +37.8%
Value US$2,457,750
Transaction date
Purchase
Price
212.04
Quantity 50,644
Value US$4,949,504
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-13 2026-02-12
B Purchase
82,590 -15.8%
191.66
US$1,470,206 		82,590 -15.8% 191.66 US$1,470,206
2025-07-18 2025-07-17
B Purchase
40,442 +37.8%
270.85
US$2,457,750 		40,442 +37.8% 270.85 US$2,457,750
2022-06-14 2022-06-14
B Purchase
50,644
212.04
US$4,949,504 		50,644 212.04 US$4,949,504